Prot# PXD101-CLN-19: A Multicenter, Open-Label Trial of Belinostat in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date7/29/107/29/13

Funding

  • Spectrum Pharmaceutical Research Corporation (PXD101-CLN-19)